|
Miyamoto S et al. [26]
|
2009
|
F
|
61
|
AC
|
IV
|
30
|
S-1 + CDDP
|
CR
|
Disease-free for 20 months
|
|
Kuga Y et al. [27]
|
2009
|
F
|
76
|
AC
|
III
|
50
|
S-1 + CDDP
|
CR
|
NR
|
|
Shiozawa M et al. [28]
|
2010
|
F
|
48
|
AC
|
III
|
60
|
S-1 + MMC
|
CR
|
Disease-free for 2 years 7 months
|
| | |
F
|
65
|
AC
|
III
|
55.8
|
S-1 + MMC
|
CR
|
Disease-free for 2 years 4 months
|
| | |
F
|
71
|
AC
|
III
|
58.0
|
S-1 + MMC
|
CR
|
Disease-free for 8 months
|
|
Hata T et al. [29]
|
2011
|
F
|
53
|
AC
|
I
|
45
|
S-1 alone
|
CR
|
NR
|
|
Baba H et al. [30]
|
2011
|
F
|
79
|
AC
|
III
|
66
|
S-1 alone
|
CR
|
Disease-free for 10 months
|
|
Nitori N et al. [31]
|
2011
|
F
|
58
|
AC
|
IV
|
30
|
S-1 + CDDP
|
NR
|
Dead at 16 months
|
|
Kuroda M et al. [32]
|
2012
|
F
|
81
|
AC
|
IV
|
50.4
|
S-1 + CDDP
|
CR
|
Disease-free for 1 year 3 months
|
|
Sato H et al. [33]
|
2012
|
F
|
83
|
AC
|
II
|
60
|
S-1 alone
|
CR
|
Local recurrence at 9 months and dead at 15 months after CRT
|
|
Murata K et al. [34]
|
2012
|
F
|
76
|
AC
|
II
|
60
|
S-1 alone
|
CR
|
Recurrence at 2 years
|
